Serum Pentraxin 3 as Promising Biomarker for the Long-Lasting Inflammatory Response of COVID-19.
COVID-19
Pentraxin 3 (PTX3)
SARS-CoV-2
cytokine storm
immunopathology
inflammation
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
17 Sep 2023
17 Sep 2023
Historique:
received:
03
08
2023
revised:
06
09
2023
accepted:
14
09
2023
medline:
28
9
2023
pubmed:
28
9
2023
entrez:
28
9
2023
Statut:
epublish
Résumé
Currently, biological markers for COVID-19 disease severity still constitute the main goal of enhancing an efficient treatment to reduce critical consequences such as an abnormal systemic inflammatory response. In this regard, the latest research has shown that Pentraxin 3 (PTX3), a highly conserved innate immunity protein, may serve as a valuable biochemical marker. Based on this evidence, we conducted a case-control study to compare the PTX3 serum levels and several immune-inflammatory mediators of 80 healthcare workers who were subdivided into subjects who were previously infected with SARS-CoV-2 (
Identifiants
pubmed: 37762499
pii: ijms241814195
doi: 10.3390/ijms241814195
pmc: PMC10531731
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Mar Drugs. 2023 May 13;21(5):
pubmed: 37233492
Nat Commun. 2021 Jun 7;12(1):3406
pubmed: 34099652
Immunity. 2020 Jul 14;53(1):19-25
pubmed: 32610079
Front Public Health. 2020 May 29;8:241
pubmed: 32574307
J Womens Health (Larchmt). 2022 May;31(5):620-630
pubmed: 35333613
Nat Immunol. 2022 Feb;23(2):275-286
pubmed: 35102342
Diabetes Metab Syndr. 2021 May-Jun;15(3):869-875
pubmed: 33892403
Front Immunol. 2021 Oct 22;12:741061
pubmed: 34745112
Physiol Rev. 2018 Apr 1;98(2):623-639
pubmed: 29412047
JAMA Netw Open. 2022 Aug 1;5(8):e2228008
pubmed: 35994285
Nat Rev Microbiol. 2021 Nov;19(11):685-700
pubmed: 34535791
J Innate Immun. 2022;14(5):493-501
pubmed: 35066500
J Hepatol. 2016 Jun;64(6):1416-27
pubmed: 26921689
Front Immunol. 2021 Jun 21;12:676702
pubmed: 34276664
Methods Mol Biol. 2016;1417:1-43
pubmed: 27221479
Nature. 2023 Jan;613(7942):130-137
pubmed: 36517599
Front Immunol. 2018 Dec 19;9:3046
pubmed: 30619374
Ann Med. 2022 Dec;54(1):1473-1487
pubmed: 35594336
Cytokine Growth Factor Rev. 2021 Apr;58:102-110
pubmed: 32988728
Crit Care. 2020 Aug 27;24(1):525
pubmed: 32854750
Nat Immunol. 2021 Jan;22(1):19-24
pubmed: 33208929
Biol Sex Differ. 2021 Dec 20;12(1):66
pubmed: 34930441
Biosci Rep. 2020 Feb 28;40(2):
pubmed: 31957804
J Immunol. 2008 Mar 1;180(5):3391-8
pubmed: 18292565
Expert Rev Clin Pharmacol. 2021 May;14(5):601-621
pubmed: 33705239
Cell Rep Med. 2022 Jun 21;3(6):100663
pubmed: 35732153
Biomedicines. 2022 Oct 01;10(10):
pubmed: 36289725
Annu Rev Immunol. 2010;28:157-83
pubmed: 19968561
Lab Invest. 2012 Sep;92(9):1285-96
pubmed: 22732935
J Med Virol. 2021 Jan;93(1):250-256
pubmed: 32592501
Int J Clin Exp Pathol. 2021 Jul 15;14(7):831-844
pubmed: 34367415
Womens Health (Lond). 2021 Jan-Dec;17:17455065211022262
pubmed: 34096383
J Clin Med. 2022 Jul 25;11(15):
pubmed: 35893393
Future Virol. 2022 Mar;:
pubmed: 35462619
JAMA Netw Open. 2021 Dec 1;4(12):e2137257
pubmed: 34905008
Cureus. 2022 Apr 24;14(4):e24438
pubmed: 35637828
Int Arch Allergy Immunol. 2014;165(3):165-78
pubmed: 25531094
Front Immunol. 2021 Aug 20;12:681516
pubmed: 34489933
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Nat Immunol. 2022 Feb;23(2):210-216
pubmed: 35027728
Biomedicines. 2022 Apr 19;10(5):
pubmed: 35625677
Immunol Lett. 2014 Sep;161(1):38-43
pubmed: 24792672
Int J Mol Sci. 2021 Apr 10;22(8):
pubmed: 33920318
Front Immunol. 2020 Aug 07;11:1949
pubmed: 32849654
Oncogene. 2019 Jul;38(30):5873-5889
pubmed: 31253871
Nat Rev Microbiol. 2023 Mar;21(3):133-146
pubmed: 36639608
Antioxidants (Basel). 2023 Jun 15;12(6):
pubmed: 37372008
Front Med (Lausanne). 2023 Mar 31;10:1011936
pubmed: 37064029
Sci Rep. 2021 Aug 9;11(1):16144
pubmed: 34373540
Blood. 2006 Nov 15;108(10):3387-96
pubmed: 16840729
Turk J Med Sci. 2020 Dec 14;51(2):448-453
pubmed: 33315349
Front Immunol. 2022 Oct 28;13:933960
pubmed: 36389697
Nat Med. 2020 Oct;26(10):1636-1643
pubmed: 32839624
Science. 2020 Aug 7;369(6504):718-724
pubmed: 32661059
Front Immunol. 2019 Apr 12;10:794
pubmed: 31031772
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652
Int J Mol Sci. 2023 Feb 10;24(4):
pubmed: 36834949
Front Immunol. 2019 Apr 04;10:712
pubmed: 31019517
J Comp Eff Res. 2022 Jun;11(9):689-698
pubmed: 35510532